Apalutamide-Induced Hypothyroidism Associated With Increased Thyroid Hormone Clearance in Metastatic Prostate Cancer Patient: A Case Report
{{output}}
Introduction: Apalutamide (APA) is an androgen receptor signaling inhibitor widely used for metastatic hormone-sensitive prostate cancer (mHSPC), though it can induce hypothyroidism. We report a severe case of APA-induced hypothy... ...
